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Abstract 
BACKGROUND: Meningiomas are the type of central nervous system tumours, derived from the cells of the 
arachnoid membrane that are well constrained from surrounding tissues, mainly no infiltrating neoplasm with 
benign features. Meningiomas consist about 15-20% of all primary intracranial neoplasms.  
AIM: The evaluation of the outcome of the operatively treated meningiomas in relation with the Karnofsky 
performance score, survival, recurrence, type of the surgical excision, histological type, mitotic count (MC), 
localisation and volume of the lesion 
METHODS: In this article 40 operatively treated patients are reviewed for the outcome of the operation about the 
Karnofsky performance score, survival, recurrence, type of the surgical excision, histological type, mitotic count 
(MC), localisation and volume of the lesion. 
RESULTS: Association/interconnection between the mitotic count grade I and the regrowth of meningioma have 
been verified. Association/interconnection between the mitotic count grade I and the regrowth of meningioma 
have been verified. Association/interconnection between the mitotic count grade I and the regrowth of 
meningioma have been established.  
CONCLUSION: Gender, age and Karnofsky performance score have predictive value in the treatment of different 
types of meningiomas. The magnitude of surgical resection is associated with the regrowth of a tumour. The 
mitotic count in different types of meningiomas presents significant feature in the appearance of meningioma 
recurrence. The surgical resection and the quality and quantity of patient’s survival have a significant relation to 
the mitotic count of the meningiomas. There is no connection between the size and the localisation of a tumour 
related to different values of the mitotic count. 
 
 
 
 
 
 
Introduction 
 
Meningiomas are slow-growing tumours of the 
central nervous system that are well-limited from 
surrounding tissues, mainly non-infiltrative neoplasms 
with benign characteristics. Among the meningiomas, 
some of the histologically described are malignant 
forms, which include 1.7% of all meningiomas, as well 
as fast-growing variants that act as malignant tumours 
[1]. The origin of these tumours is derived from the 
arachnoid cells. Usually, meningioma’s are single, 
solitary, but can also be multiple - up to 8% of cases, 
which is more common in neurofibromatosis [2]. The 
growth of meningiomas is expansive, followed with 
displacement and compression of the surrounding 
structures, the brain, blood vessels, cranial nerves, 
etc., but there are also forms of diffusional thickening 
of the brain membranes, a type of meningioma called 
meningioma en plaque [3]. Meningiomas can grow 
everywhere that arachnoid membrane is found 
(between the brain and the cranium, in the ventricles, 
down the spinal canal). The ectopic meningiomas may 
be found growing in the inside of the bone which limits 
the cranial box-as primary intraosseal meningeomas.4 
Meningiomas account for 14.3-19% of all primary 
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intracranial neoplasms. They are the second most 
common primary tumour of the central nervous 
system, just behind the gliomas (43%), and the 
pituitary adenomas (17%) in the third place. The peak 
of incidental occurrence of this group of neoplasms is 
45 years of age. The gender distribution of 
meningiomas is almost twice as high in females (men: 
women = 1: 1.8). Meningiomas in childhood and 
adolescence account for 1.5% of the total number [3].
 
Meningioma’s most frequent distribution is as follows: 
parasagittal (20.8%), then convexity (15.2%), and 
tuberculum sellae (12.8%), followed by localization: 
sphenoid ridge, olfactory groove, falx, lateral 
ventriculi, tentorium, the middle fossa, the orbit, the 
spinal channel, the Sylvian fissure, extracalvarial, 
multiple localization, the pontocerebral angle, the 
sphenoidal plane, and the foramen magnum. Around 
60-70% of all meningiomas have falcian distribution 
(including parasagittal distribution), sphenoid wing 
(including tuberculum sellae), or on the convexity of 
the brain. Meningiomas rarely occur in the pediatric 
population, and 28% of them have intraventricular and 
posterior fossa localisation [4], [5]. 
 
Histopathological variables that determine the 
characteristics of meningiomas include tumour 
gradient, histological subtype, proliferative index and 
invasiveness of a tumour to the brain [3], [6], [7].
 
For 
our paper, the WHO Classification of Tumours of 
CNS, 2016 was used: 
1. Plain X-ray – Tumor calcifications can be 
verified (about 10%), then hyper/dysostosis or 
changes in configuration, the thickness of the skull 
(including the floor of the anterior cranial fossa in 
olfactory groove meningioma), an increase in vascular 
fissures (especially in the middle meningeal artery); 
2. Computerised tomography-The 
presentation of a tumour with this diagnostic tool 
shows a homogeneous dense mass with a wide base 
attached to the dura. The presence of psammomatous 
calcifications can be presumed through the measured 
60-70 Hounsfield units in a non-contrast series. 
Intraventricular meningiomas in 50% of patients 
produce extraventricular oedema;  
3. Nuclear Magnetic Resonance-The signal 
that a tumour gives in T1WI and T2WI may be 
isodense, but it is often intensified with contrast 
gadolinium. The brain's oedema may, but it does not 
have to be present. Nuclear magnetic resonance 
provides information about dural venous sinuses 
(accuracy in the presumption of dural sinus invasion is 
> 90%). A common sign on NMR is the dural tale; 
4. Angiography-The classical finding: 
“appears rapidly, remains long-lasting” explained that 
a tumour is visualised in the early arterial phase and 
remains visible after the completion of the venous 
phase. It is characteristic that the meningioma’s have 
arteries that arise from the external carotid artery, 
excluding the olfactory groove meningioma, whose 
nutrient vessels originates from the internal carotid 
artery (ICA), or the ethmoidal branches of the 
ophthalmic arteries, suprasellar meningiomas may be 
vascularized from the long branches of the ophthalmic 
artery and parasellar meningioma’s that are largely 
nourished by the internal carotid artery (ICA). The 
secondary vascular supply may come from the pial 
branches of the anterior, the middle and posterior 
cerebral artery. In cases of tentorial meningiomas the 
artery of Bernasconi & Cassinari or the Italian artery is 
of interest, or the artery of the tentorium (a branch of 
the meningohipophysal stem) that is enlarged in 
lesions, tumours that envelop the tentorium. 
Angiography gives excellent information on the 
involvement of the dural venous sinuses and their 
occlusion, especially in the parasagittal/falx 
meningiomas. At the same time, angiography may 
provide preoperative embolisation of a tumour [8]. 
Surgical treatment is a method of choice for 
symptomatic meningiomas. Incidental meningiomas 
without tissue oedema, vascular compromise, or 
those having clinical presentation only with epileptic 
seizures that are easily controlled with anti-epileptic 
medications, can be managed with an expectative 
approach. In general, the meningioma surgery is very 
bloody which would imply a great deal of attention to 
the hemostatic techniques during the intervention, as 
well as the possible use of autologous blood for 
transfusion donated preoperatively and also 
preoperative embolisation of the dominant tumour 
feeding artery [9]. Radiotherapy is often estimated not 
to be effective as a primary model of treatment [10]. 
The outcome in the treatment of 
meningiomas: 5 years of survival for patients with 
meningiomas is generally 91.3% [3], [11]. 
When conducting surgical removal of 
meningiomas, a system of stratification of the degree 
of excision is used, and this can describe the radically 
in the performed surgical treatment. The system for 
removing meningiomas according to Simpson covers 
5 grades:  
0) macroscopically complete removal of a 
tumour, excision of its dural attachment within 2 cm of 
no-affected dura: 
I) macroscopically complete removal of the 
tumour, with excision of its dural attachment, and of 
any abnormal bone (including resection of the venous 
sinus when involved); 
II) macroscopically complete removal of the 
tumour and its visible extensions with endothermic 
coagulation (Bovie, laser) of the dural attachments; 
III) macroscopically complete removal of an 
intradural tumour, without resection or coagulation of 
its dural attachments or its extradural extensions 
(hyperostotic bone); 
IV) partial removal, leaving intradural tumour 
in situ; 
V) simple decompression (± biopsy) [12]. 
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The study assesses the outcome through the 
disability of patients classified according to Karnofsky 
score, which evaluates psycho-physical (dis)ability as 
a percentage expressed in dozens starting from 0% 
(death) to 100% (normal patient, without symptoms 
and signs of illness) which are grouped into three 
groups:  
0-40% - the patient is not able to care for 
himself, institutional or hospital care is necessary, in 
which the patient can progress rapidly; 
50-80% - the patient is not able to work, but 
can live at home and to cope with most individual 
needs; 
80-100% - the patient can continue with 
everyday activities and work-related obligations, and 
no special care is required [3]. 
The most important prognostic factor for 
treating meningiomas is predicting possible 
recurrence and survival for malignant or transient 
types of meningiomas [13], [14]. Negative prognostic 
factors include non-extensive resection, brain invasion 
and high mitotic activity which are the most significant 
predicting factors. The extensiveness of surgical 
excision is the most important factor in the prevention 
of recurrent meningiomas. Simpson's grading system 
[12] is a valuable tool for evaluation for possible tumor 
recurrence [15], [16]. In addition to this principle, the 
basic element for the prevention of recurrent 
meningiomas, the Mitotic index is a factor with great 
significance for assessment, anticipation, planning of 
further treatment and outcome in meningiomas [12], 
[15], [16], [17]. 
By definition, the mitotic index (MI) is the sum 
of the mitotic "figures" (MF) in 10 consecutive HPF 
(High Power Field) in the zone of the highest mitotic 
activity relative to the remaining cells [18], [19]. This 
defining factor is dominant in the classification for 
meningioma’s according to the World Health 
Organization, with 3 degrees of the mitotic index being 
defined as a risk factor for local recurrence, according 
to criteria of histological analysis with prognostic 
significance [17], [20]. 
According to Perry et al., [3], [18], [19] and 
accepted by the World Health Organization, as an 
objective grading criterion, there are: benign/WHO 
Grade 1 meningioma’s that do not exceed 4 mitosis 
per 10 consecutive HPF, atypical/WHO Grade 2, with 
5-20 mitoses on HPF and anaplastic/WHO Grade 3, 
meningioma’s in which mitotic activity exceeds 20 
mitoses of 10 consecutive HPFs in the zone of the 
highest mitotic activity [3], [15], [17], [18], [19]. 
This classification (determining the mitotic 
index (MI)) has its weakness. Namely, the selection of 
zones with the "highest mitotic index" is subjective 
and subject to bias and the heterogeneity of mitotic 
activity in various areas of a tumour. Further factors of 
"error" are variations in the size of the sampled tissue 
samples, as well as the resected samples and their 
cellularity, both factors affecting the number of cells 
that can be evaluated [21].
 
To specify this method, the mitotic activity can 
be determined by introducing an 
immunohistochemical method to objectify this 
procedure. Protein Ki-67 is a nuclear protein that is 
closely related and essential in cellular proliferation. 
This protein is associated with the ribosomal RNA 
transcription [21], [22].  
The H & E (hematoxilyn & eosin) mitotic 
index, as well as the mitotic indices determined 
according to immunohistochemistry, can be identified 
as independent prognostic factors for the poor 
outcome (recurrent tumor and/or death), adjusted to 
the patient's age and extensiveness to the tumor 
resection (with STR (subtotal resection) as an 
independent factor) [17].
 
Numerous studies have shown that the mitotic 
index (in the repeat-MI text) isolated or synchronously, 
is in harmony with the occurrence of recurrence of 
meningiomas [15]. Namely, it is one of the most 
probable prognostic factors in meningiomas. The 
identification of the mitotic "figures" (MF) [23] and the 
zone of the most intensive mitotic activity in 
histological H & E coloured slides is a representative, 
cost-effective, necessary, but also a subjective task. 
The motives were the evaluation of the 
outcome of the operatively treated meningiomas 
through objective parameters, to improve the results 
of the treatment, to reduce the complications, 
disability, improving quality, and survival, as well as 
re-socialisation in correlation with the mitotic index. 
The purpose of this study is evaluation of the 
relation of the mitotic index to various groups of 
meningioma’s and tumour regrowth, assessment of 
the impact of tumour size over the time of tumour 
recurrence, assessment of the impact of tumour 
localization over the time of tumour recurrence, 
correlation between the mitotic index and the outcome 
of surgical treatment, followed by disability and 
survival evaluated according to Karnofsky Score, 
correlation between the mitotic index and the size and 
localization of the tumour, and also determination of 
the time of tumour recurrence in surgically treated 
subjects with meningiomas. 
 
 
 
Material and Methods 
 
In a retrospective study, 40 successive 
randomly selected patients with an initial diagnosis of 
intracranial supra- and infratentorial meningioma, 
treated at the Neurosurgery Clinic-Skopje, were 
processed. 
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The subject of the analysis were previously 
operated patients, without limitation in terms of 
location, gender, age, which are subject to standard 
micro-surgical excision, with a tendency to achieve 
"gross total resection" [12], i.e. maximum, radical 
surgical excision, Grades 1 and 2 according to 
Simpson, as well as patients undergoing "subtotal 
resection", respectively Grade 3, 4 and 5 according to 
Simpson. For this purpose, the technology for micro-
surgical excision was used-microinstumentarium, 
operative microscope, bipolar coagulation, ultrasonic 
aspirator. 
For surgical excision grading, and the 
radicality of the operative treatment, the previously 
mentioned evaluation system for removing 
meningiomas according to Simpson was used [12].
 
The study assesses the outcome through the 
disability of patients classified according to previously 
mentioned Karnofsky performance status, which 
assesses psycho-physical condition as a percentage 
expressed in dozens starting from 0% (death) to 
100% (normal patient without symptoms or signs of a 
disease) that are grouped together into three groups 
[3].
 
The pathohistological diagnostics was 
performed at the Institute of Pathology, Medical 
Faculty, Ss Cyril and Methodius University of Skopje, 
Skopje, Republic of Macedonia, using histological and 
immunohistochemical analyses (diagnosis, mitotic 
count, subtype-specific immunohistochemistry).  
Inclusion criteria were patients of our 
population with an initial diagnosis of intracranial 
supra- or infratentorial meningioma and exclusion 
criteria were patients with meningioma in the spinal 
canal. 
Statistical processing of data is performed in 
statistical programs STATISTICA 7.1 and SPSS 13.0. 
The following methods apply: In series with attributive 
marks percentages per structure (%) are determined; 
The association, or the differences in the analyzed 
parameters in relation to the mitotic index, tumour 
regrowth, Karnofsky score, excision grade according 
to Simpson, were tested with Pearson Chi-square (); 
In series with numerical records determined are: 
Descriptive statistics (Mean ± Std. Dev., ± 95% CI, 
Min., Max.); The ratio between the mitotic index and 
the recurrence period; Karnofsky score; tumour size; 
Determined with Spearman Rank Order Correlations 
(R); The influence of size and tumour localization as 
independent variables on the occurrence of tumour 
growth as a dependent variable; the influence of the 
mitotic index and surgical excision as independent 
variables on the occurrence of tumour recurrence as a 
dependent variable was determined using Logistic 
regression analysis (Chi Square, Wald, Exp (B)); The 
re-emergence of a tumour, tumour size, years, patient 
age, the time of occurrence of the first symptoms as 
independent variables, on the independent living as a 
dependent variable, was determined using Logistic 
regression analysis (Chi Square, Wald, Exp (B)). 
 
 
Results  
 
Of the 40 enrolled patients 13 (32.5%) were 
male, 27 (67.5%) were female. Mean age was 58.58 ± 
8.91 years of age, with minimal age of 42 and 
maximal age of 78.  
 
Figure 1: Distribution of the patients according to the gender 
 
Average lesion volume was estimated to be 
40.23 ± 16.39 cm, with a minimal volume of 7 ccm 
and maximal volume of 80.00 ccm.  
 
Figure 2: Distribution of the patients according to the histological 
type 
 
According to the histological type 32 patients 
or 80% had a typical meningioma, 7 patients or 17.5% 
had an atypical meningioma, and one patient (2.5%) 
had anaplastic meningioma.  
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Figure 3: Distribution of the patients according to the localisation of 
a tumour 
 
The localisation of a tumour was divided into 
three sections: convexity, cranial base and falx-
tentorium. In 18 patients (45%) the meningioma was 
localised on the cranial base, 12 patients (30%) had a 
meningioma localised on falx-tentorium, 10 patients 
(25%) had a convexity meningioma. 
 
Figure 4: Distribution of the patients according to the surgical 
excision/tumour recurrence (left); according to the surgical 
excision/Karnofsky scale (right) 
 
According to the mitotic count 34 patients 
(85%) had a Grade I, four patients (10%) had a Grade 
II and 2 patients (5%) had a Grade III mitotic count. 
 
Figure 5: Distribution of the patients according to the mitotic count 
Disability and survival were evaluated 
according to Karnofsky Performance Scale with the 
following results: 32 patients (80%) had a score of 
80% or higher, 7 patients (17.5%) had a score from 
50-80% and 1 patient (2.5%) had a score of 50% or 
lower. 
 
Figure 6: Mitotic count (MC) recidive of a tumour 
 
Simpson scale was used for grading of the 
degree of excision: 24 patients (60%) had a Simpson I 
resection, 12 patients (30%) had a Simpson II 
resection, and 4 patients (10%) had Simpson III 
resection. 
 
Figure 7: Karnofsky performance scale 
 
In 29 patients (72.5%) no tumour regrowth 
was noted after the first operation, and in 11 patient 
(27.5%) tumour regrowth was diagnosed.  
 
Figure 8: Surgical excision (Simpson) (left); Outcome after the 1
st
 
operation (right) 
 
 
 
Discussion  
 
Meningiomas represent 13 to 26% of all 
intracranial tumours with an annual incidence of 6 
cases per 100 000 people [24]. Although these 
tumours behave like benign tumours, they are still 
associated with significant morbidity and mortality 
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[18], [25]. In 1993, the World Health Organization 
(WHO) proposed a classification of meningioma’s in 
three groups: classic or typical (WHO Group I), 
atypical (WHO Group II) and malignant (WHO Group 
III) [27]. Depending on the diagnostic criteria used in 
different studies, the atypical meningiomas are 
represented with 5 to 17%, whereas the malignant 
meningiomas range from 1 to 3%, while the rest 
remains on the classic, typical meningiomas [8], [18], 
[24], [26]. 
In this study, according to the use of the 
mitotic index and the pathophysiological diagnosis, 
typical meningiomas were represented with 80% 
(32/40) of cases, atypical meningiomas in 17% (7/40) 
of cases and one case of anaplastic, malignant 
meningioma, or 2.5% (1/40), which is in accordance 
with the representation of the subgroups of 
meningiomas published in the professional literature 
[3], [8], [9], [18], [24], [27]. 
The pathophysiological criteria used for 
classification of meningiomas include the following 
estimates: the mitotic index, the presence of atypical 
mitosis, necrosis, significant pleomorphism, 
macronucleus, disrupted histoarchitectonics, 
hypercellularity, the presence of mosaic tissue, the 
presence of brain invasion, even the minimum 
presence of a focally clear malignant behaviour 
(cancer-like, sarcoma or melanoma) [28]. 
According to the classification of brain 
tumours published by the World Health Organization 
in 2007, all meningioma’s that exhibit a brain tissue 
invasion were set in the higher group, WHO Group II 
[8]. Usability of the brain invasion as a marker of the 
aggressiveness of the tumour is limited, since the 
brain tissue can be identified in a small number of 
surgical specimens, and is rarely recorded by the 
pathologists [18], [24], [26]. Using these criteria, 
Andrej Vranic, Mara Popovic, Andrej Cör, Borut 
Prestor and Joze Pizem published a series of patients 
with the representation of atypical meningiomas in 76 
cases (88%) and 10 patients with malignant 
meningioma (12%). In this paper, 7 patients had 
atypical meningioma (17%), and one case of 
anaplastic meningioma (13%) was enrolled. In the 
professional literature [26], the ratio of atypical and 
malignant meningioma’s in the interrelated correlation 
is 1.5:1 to 6:1. In the study of Slovenian authors, this 
ratio equals 7.6:1, while in our study 7: 1. Benign 
meningiomas are more common in the female 
population (female: male ratio is approximately 2:1), 
while atypical and malignant meningiomas are more 
common in the male population (the ratio of women to 
men is 0.8-1.4: 1). In the series of Slovenian 
colleagues, the ratio of women to men is 1.1:1, while 
in our study this ratio is 1.6:1, while in the benign 
form, the ratio according to the gender female: male 
equals 2.2:1. In the previously cited study of the 
Slovenian authors, during the patient's follow-up, 
tumor regrowth was noted in 31 patients (36%), in the 
period from 4 to 76 months (median of 31), while in 
our study there were 11 patients, that is, 27.50% 
without tumour regrowth in the interval of 14.36 ± 
7.10, i.e. the minimum re-occurring time from 8 
months to the maximum re-occurrence time of 28 
months.  
The significance of the extensiveness of 
surgical resection is equally important for all 
histological subtypes of meningiomas [18], [25]. 
Sometimes it is difficult to compare the results 
between studies because the tumour resection in 
some studies is graded according to Simpson [11], 
[29] while in the other it is graded as a total or subtotal 
resection (gross total vs subtotal resection, GTR vs 
STR) [18], [25], [30]. In the study of Slovenian 
authors, Simpson I excision was achieved in 47% of 
patients, and total resection (as GTR) (including 
Simpson I and II) was achieved at 90%. The non-
recurring period of patients with Simpson I excision 
was longer compared to patients with Simpson II-IV 
excision, but there were no statistically significant 
observations. 
In the study of Donald Simpson of the 
Department of Neurological Surgery, Radcliffe 
Infirmary, Oxford, 90 operations were made according 
to Simpson I, in which beside tumour extirpation, the 
dural attachment and extradural extensions were 
removed so that 8 cases of relapse occur later, or 9% 
[12]. Of the 114 operations performed according to 
Simpson II, in which the visible tumour was 
completely removed, while the dural adherence was 
coagulated with the endotherm coagulation, 18 
relapses or 19% were observed. For operations that 
are considered incomplete (Simpson III, IV, V), the 
rate of recurrence is more significant, but it is 
important to note that a large number of patients 
treated with limited excision gain a long period of relief 
[12].  
In our study, of the 40 patients with 
meningioma treated surgically, in 24 patients (60.0%) 
maximally radical surgical excision was achieved, 
grade I according to Simpson, of which 4 patients 
(10.0%) had a tumour recurrence. In 12 patients 
(30.0%), surgical excision grade II was performed by 
Simpson, and 6 of them (15.0%) had a tumour 
recurrence. Four patients (10.0%) performed surgical 
excision grade III according to Simpson, 1 patient 
(2.5%) had a recurrence of the tumour, and for all 
within the defined period of follow-up. There is no 
significant difference in the reported distribution of 
data on the degree of surgical excision graded by 
Simpson and the incidence of tumour regrowth, for 

2
= 4.47 and p > 0.05 (p = 0.11). 
When patients are grouped according to the 
histological type of the meningioma, than those with 
benign form-typical meningioma, have a 5-year 
survival of 75%, while those with atypical and 
anaplastic meningioma have a rate of a 5-year 
survival rate of 70% and 56%, respectively. The 
prognostic factors for survival in benign tumours 
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include the patient's age in the time of setting the 
diagnosis, tumour size, institution (the 
manner/standard of treatment) in which the patient 
was treated; for malignant tumours the age at the time 
of diagnosis is important. The five-year recurrence 
rate of the symptoms (regardless of the choice of 
treatment of the disease) equalled 18.2% for benign 
tumours and 27.5% for patients with malignant 
meningiomas. In patients with benign meningioma, 
who were susceptible to complete eradication, the 5-
year reappearance rate equalled 20.5%. 
It was shown that women have a higher 
prevalence of all three histological types of 
meningiomas, compared with men, with no racial 
difference in the representation of meningiomas. Age 
is an important predictor of mortality in patients with 
benign, atypical and malignant meningiomas. As the 
age of the diagnosis increases, the survival rate 
decreases dramatically, although the exact cause of 
death in patients is not taken into consideration, 
depending on or regardless of the primary illness. Age 
and race are considered as individual prognostic 
factors for benign and malignant meningiomas. 
According to the study, the 5-year tumour 
recurrence rate that was previously completely 
surgically eliminated equalled 20.5%, which is higher 
than that quoted in the literature [3], [15], [20], [26], 
[27], [31], [32]. 
Mirimanoff et al., [32] recognised that the rate 
of re-emergence of benign meningiomas previously 
operatively treated was 7% for 5 years and 20% for 10 
years. The recurrence rate in the Mirimanoff et al., 
[20] study accounted for 2% throughout 5 years. In 
this study, the recurrence time for medium-term time 
is 14.36 ± 7.10 months, that is, at least 8 months and 
a maximum of 28 months. 
Complete surgical tumour excision is referred 
to as gross total resection (GTR), which is defined as 
Simpson grade I or II, which corresponds to a 
macroscopically performed tumour resection with 
bipolar coagulation of the dural insertion. Any other 
type of tumour resection would be understood as 
subtotal resection (or STR). Pathologists in the study 
assessed the mitotic activity of the tumour through the 
determination of the mitotic index with classical H & E 
colouration, immunohistochemistry with monoclonal 
anti-PHH3 (phosphohistone H3) antibody and 
immunohistochemistry technique with a monoclonal 
anti-Ki-67 antibody [17], [21]. 
The following results were obtained in the 
determination of the mitotic index (MI): 251 WHO 
grade I, 45 atypical meningioma’s (WHO grade II) and 
5 malignant (anaplastic) meningioma’s (WHO grade 
III). In operative treatment, 238 cases had GTR, while 
27 patients had STR. The recurrence rate in the study 
equaled 12.5% (i.e. 33 patients) with a relative risk for 
tumor regrowth significantly higher in patients treated 
with subtotal resection (STR), (10/27; RR = 37%) 
compared with those treated with radical resection 
(GTR) (23/238; RR = 9.7%). The average recurrence 
time was 45 months (48 months after GTR and 36 
months per STR). The meningioma recurrence rate 
with WHO grade I level equalled 6.0% for tumour 
GTR, or 9.8% in the total cohort. Reproducibility was 
recorded at 18% for meningiomas with the WHO 
grade II mitotic index, while for meningiomas with 
grade III mitotic index, according to the WHO, 
recurrence equalled 80%. In the pathophysiological 
assessment of tumours, in addition to cell proliferation 
and cellular abnormalities, the potential of the tumor 
for invasion in the brain parenchyma was considered, 
with the type of tumour being labelled as possibly 
invasive meningioma. Of the examined series, brain 
invasiveness was registered in 14 tumours with the 
following distribution-12 tumours in grade II and 2 in 
grade III of the WHO (of which, 4 brain tissue-invasive 
recurrent meningioma’s with a relative risk of 29%). 
The study compares the importance and efficiency of 
the mitotic index measured by the traditional way of 
histological preparations according to H&E, as well as 
the use of monoclonal anti-phosphohistone H3 
(PHH3) antibodies and monoclonal anti-Ki 67 
antibodies in immunohistochemistry of the 
preparations. The MI (MI) H & E and MI PHH3 can be 
identified as independent predictors (predictors) of 
poor prognosis (recurrence and/or death) adjusted to 
the age and extensiveness of surgical tumour 
resection (and STR as an independent variable). 
Following the WHO-recommended mitotic 
indexing guidelines, a lower threshold for mitotic 
activity, i.e. a mitotic index of 4 and more mitotic 
figures of 10 large-scale magnifications (HPF) was 
proposed, at the point of high risk of tumour 
recurrence and / or death. MI according to H & E is an 
independent indicator of unfavourable prognosis, as 
proposed by Perry et al., [18], [33]. 
In our study, we have the following data on 
the significance of the mitotic index in the prognosis: 
out of the total extirpated meningioma’s (40 in all), 34 
meningiomas, (85%) pathohistologically classified 
based on mitotic index in grade I according to the 
WHO, 4 meningioma’s (10%) are classified according 
to the mitotic index in grade II according to the WHO 
and 2 meningiomas (5%) classified according to the 
mitotic index in degree III according to the WHO. 
As for the examined correlation between the 
mitotic tumor index and the localization of the tumor, 
34 (85, 00%) patients registered a mitotic index of 
grade I, of whom 15 (37, 50%) patients had a 
localized tumour on the skull base, 10 (25, 00%) 
patients had a tumor localized to falx-tentorium, and in 
9 (22, 50%) patients the tumor was localized to 
convexity. In 4 (10.00%) patients a mitotic index of 
grade II was registered, of which 2 (5.00%) patients 
had a tumour localized to the skull base, 1 (2.50%) 
the patient had a tumor localized to the falx-tentorium, 
and 1 (2.50%) the patient had a localized convexity 
tumour. Two patients (5.00%) had a mitotic index of 
grade III, of which 1 (2.50%) the patient had a tumor 
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localised to the skull base, and 1 (2.50%) patient had 
a tumor localized to the falx-tentorium. For 
2
 = 0.87 
and p > 0.05 (p = 0.93), there is no significant 
difference in the displayed distribution between the 
level of the mitotic index and the localization of the 
tumour. 
Grading of work capacity and disability was 
done according to the Karnofsky Performance Score, 
which as an average for patients in Akagami Ryojo's 
study, Napolitano Mario, Sekhar Laligam equalled 83 
± 10%. Ninety-seven per cent of patients were 
satisfied with the treatment, expectations were fulfilled 
in 90%, and according to the Karnofsky index, 83% of 
patients were labour-efficient. In this study, the 
comparison is as follows: 40 patients, of which 13 
men and 27 women were studied, at a mean age of 
58.58 ± 8.91 years. Gross total resection (Simpson 
grade I) was achieved in 24 patients (60%) and 
Simpson grade II was achieved in 12 patients (30%) 
in a total of 90% of patients. The mean tumour volume 
was 40.23 ± 16.39 cc. The work capacity assessment 
and the capacity for independent living, conducted 
according to Karnofsky, 80% of the patients were able 
to live independently with the possibility of returning to 
their jobs, 17.5% cannot fulfil their previous working 
capacity, but can independently function and can fulfil 
their own individual need, while 2.5%, that is, one 
patient, is not able to care for himself, that is, he 
needs an institutional type of care [34], [3]. 
In conclusion, the results have shown that 
gender, age and Karnofsky performance score have 
predictive value in the treatment of different types of 
meningiomas. Also, the magnitude of surgical 
resection is associated with the regrowth of a tumour. 
The mitotic count in different types of meningiomas, 
as an independent predictor, represents a significant 
feature in the appearance of meningioma recurrence. 
The surgical resection and the quality and quantity of 
patient survival have a significant relation to the 
mitotic count of the meningiomas. Results have also 
demonstrated that there is no connection between the 
size and the localisation of a tumour related to 
different values of the mitotic count. 
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